
ModeX’s Dr. John Mascola will be at World Vaccine Congress 2026 to discuss the development of unique tetravalent antibodies for COVID and influenza highlighting ModeX’s work in this area. If you are at the Congress, drop in and join the conversation. @jrmascola











